Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.53 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.52 |
| ▸ | MYC | P01106 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | TTR | P02766 | 1/20 | 0.49 |
| ▸ | EIF4E | P06730 | 1/20 | 0.47 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | METAP2 | P50579 | 1/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.45 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.45 |
| ▸ | KDM5A | P29375 | 1/20 | 0.44 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.44 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.44 |
| ▸ | DHODH | Q02127 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4371510 | 0.89 | GAA (0.59) | CSNK2A1MYCPOLBGAATTR | |
| SCHEMBL6702122 | 0.87 | MYC (0.58) | CSNK2A1MYCPOLBGAAEIF4E | |
| SCHEMBL18116578 | 0.87 | CSNK2A1 (0.57) | CSNK2A1MYCPOLBGAAEIF4E | |
| SCHEMBL4621112 | 0.87 | CSNK2A1 (0.65) | MCL1CSNK2A1POLBGAATTR | |
| SCHEMBL29064695 | 0.86 | MYC (0.56) | MCL1CSNK2A1MYCPOLBGAA | |
| SCHEMBL4915994 | 0.84 | TTR (0.51) | MCL1MYCPOLBTTREIF4E | |
| SCHEMBL14397372 | 0.84 | POLB (0.53) | CSNK2A1MYCPOLBGAATTR | |
| SCHEMBL11080302 | 0.84 | EIF4E (0.52) | MCL1MYCEIF4EFOLH1 | |
| SCHEMBL9534481 | 0.83 | MYC (0.60) | MCL1MYCGAATTRFOLH1 | |
| SCHEMBL30755384 | 0.83 | MYC (0.71) | MCL1MYCPOLBGAAFOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7943781-B2 | Process for preparing telmisartan | DR. REDDY'S LABORATORIES LIMITED (IN) | 2011-05-17 | — | — | US | disclosed |
| EP-1805146-A4 | PROCESS FOR PREPARING TELMISARTAN | REDDYS LAB LTD DR (IN) | 2009-01-14 | — | — | EP | disclosed |
| US-20070287840-A1 | Process for Preparing Telmisartan | DR. REDDY'S LABORATORIES LIMITED (IN) | 2007-12-13 | — | — | US | disclosed |
| EP-1805146-A2 | PROCESS FOR PREPARING TELMISARTAN | Dr. Reddy's Laboratories Ltd. (IN) | 2007-07-11 | — | — | EP | disclosed |
| WO-2006044754-A2 | PROCESS FOR PREPARING TELMISARTAN | DR. REDDY'S LABORATORIES LTD. (IN) | 2006-04-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070287840-A1 | Process for Preparing Telmisartan | AGT, TTR, REN | MCL1 4092/4885CSNK2A1 1812/4885MYC 3253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.